[Comment] Redefining consolidation in primary CNS lymphoma: autologous stem-cell transplantation as the standard

Summary

This is a medical commentary discussing treatment principles for primary CNS lymphoma, focusing on induction therapy with high-dose methotrexate-based polychemotherapy and post-induction consolidation strategies, including autologous stem-cell transplantation. No clinical trial data, regulatory decisions, or company-specific developments are reported.